F16 IL2 fusion protein (Philogen)
N/A
Report date: 2022/07/22 20:00:33
Base Information
Drug NameF16 IL2 fusion protein (Philogen)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhilogen Spa
China Registration ClassN/A
Develop Information
Active CompaniesPhilogen Spa
Inactive CompaniesUniversity Of Wisconsin-MadisonUniversity Of Washington
Active Indications
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A